Dagmar Angela Bubnoff

Research activity per year

Filter

2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma (Nature Medicine, (2019), 25, 12, (1916-1927), 10.1038/s41591-019-0654-5)
Liu, D., Schilling, B., Liu, D., Sucker, A., Livingstone, E., Jerby-Arnon, L., Zimmer, L., Gutzmer, R., Satzger, I., Loquai, C., Grabbe, S., Vokes, N., Margolis, C. A., Conway, J., He, M. X., Elmarakeby, H., Dietlein, F., Miao, D., Tracy, A., Gogas, H., & 16 othersGoldinger, S. M., Utikal, J., Blank, C. U., Rauschenberg, R., von Bubnoff, D., Krackhardt, A., Weide, B., Haferkamp, S., Kiecker, F., Izar, B., Garraway, L., Regev, A., Flaherty, K., Paschen, A., Van Allen, E. M. & Schadendorf, D., 01.07.2020, In: Nature Medicine. 26, 7, p. 1147 1 p.
Research output: Journal Articles › Comments/Debates
2003
New jobs for an old enzyme: the revival of IDO
von Bubnoff, D., Koch, S. & Bieber, T., 06.2003, In: Trends in Immunology. 24, 6, p. 296-297 2 p.
Research output: Journal Articles › Comments/Debates
3 Citations (Scopus)

Bubnoff Dagmar Angela